Table 2 Anthropometric data and clinical outcome of the study population

All (n = 123)

MDR (n = 43)

Susceptible (n = 80)

p-value

Gestational age in weeks (median, [IQR])

37 [34;39]

37 [34;39]

37 [33;39]

0.76

Birth weight (mean ± SD; kg)

2.62 ± 0.93

2.52 ± 1.05

2.67 ± 0.87

0.49

BMI (mean ± SD; kg/m²)

14.02 ± 4.21

13.65 ± 4.62

14.25 ± 3.95

0.47

 Pulmonary

65 (53)

25 (58)

40 (50)

0.39

 Cardiosurgical

80 (65)

27 (63)

53 (66)

0.70

 Neurological

60 (50)

20 (47)

42 (53)

0.53

 Gastroenterological

61 (50)

26 (61)

35 (44)

0.08

 Hematooncological

10 (8)

3 (7)

7 (9)

0.73

 Immunodeficiency

4 (3)

4 (9)

0 (0)

0.006

CVC in place, n (%)

62 (66)

24 (55)

38 (48)

0.48

CVC days (median, [IQR])

2.5 [0;8]

3 [0;9]

2 [0;7]

0.36

Days of antibiotic pre-exposure^a (median, [IQR])

2 [0;7]

4 [0;9]

2 [0;5]

0.2

Ventilated days (median, [IQR])

7 [3;18]

6 [3;19]

8 [2;16]

0.91

PICU length of stay (median, [IQR])

14 [7;32]

14 [6;32]

14.5 [7;33]

0.89

VAP Incidence, n (%)

18 (15)

9 (21)

9 (11)

0.15

All-cause mortality, 6 months, n (%)

17 (14)

8 (20)

9 (11)

0.22